Commpete supports the ACCC’s intention to determine the MTAS price for the forthcoming period based on international benchmarking. We also broadly support the approach adopted by Analysys Mason (Analysys) given the methodological constraints imposed by the ACCC’s earlier decisions (e.g. to use only publicly available models capable of producing a LRIC+ result).
Advocacy
Our alliance advocates strongly for real competition – To Legislators, Regulators and the Australian Public.